Showing results (971-980 of 982) with videos related to
Sort By:
Pageof 99
Reumatologia Clinica|November 3, 2018
Evaluation of the Educational Needs in Argentine Patients with Rheumatoid Arthritis Using the SpENAT QuestionnaireSilvana Pérez, María Santa Cruz, Julia Sosa, et al.Environmental Health Perspectives|December 6, 2008
Meeting report: risk assessment of tamiflu use under pandemic conditionsAndrew C Singer, Bruce M Howard, Andrew C Johnson, et al.Physical Review Letters|September 26, 2022
Final Result on the Neutrinoless Double Beta Decay of ^{82}Se with CUPID-0O Azzolini, J W Beeman, F Bellini, et al.BMJ (Clinical Research Ed.)|January 24, 2014
Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE ProjectGiulia Cesaroni, Francesco Forastiere, Massimo Stafoggia, et al.Journal of Bacteriology|November 30, 2011
Complete genome sequence of Corynebacterium pseudotuberculosis strain CIP 52.97, isolated from a horse in KenyaLouise Teixeira Cerdeira, Maria Paula Cruz Schneider, Anne Cybelle Pinto, et al.Environmental Health Perspectives|May 20, 2014
Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE projectMassimo Stafoggia, Giulia Cesaroni, Annette Peters, et al.Physical Review Letters|December 15, 2023
Measurement of the 2νββ Decay Half-Life of ^{82}Se with the Global CUPID-0 Background ModelO Azzolini, J W Beeman, F Bellini, et al.Environmental Health Perspectives|May 20, 2014
Arterial blood pressure and long-term exposure to traffic-related air pollution: an analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE)Kateryna B Fuks, Gudrun Weinmayr, Maria Foraster, et al.The New England Journal of Medicine|May 24, 2023
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Masatoshi Koga, Daniel Strbian, et al.Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.Pageof 99